• Join
  • Login
  • Contact

Search abstracts

Using Immunoassay technique to determine clinical efficacy of a biosimilar Filgrastim with reference Filgrastim

  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • By: ABOTALEB, Abdalla (Ministry of health, post marketing survillance, cairo, Egypt)
  • Co-author(s): Nahla kotb: Lot release, NORCB, cairo, Egypt
    Abdalla Abotaleb: post marketing survillance, NORCB, cairo, Egypt
    Doaa Mohamed: Lot release, NORCB, cairo, Egypt
  • Abstract:


    Over the next few years, the field of Biosimilars is expected to rapidly expand with the imminent patent expiry of a number of important biopharmaceuticals. Which raise a question 

    How regulatory body use a simple, accurate, effective technique to Guarantee   safety and efficacy of Biosimilars products?


    Conducting methods can help


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses